Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Continuous vs Short Infusions of Ceftazidime in Cystic Fibrosis
NCT00333385Phase 4Terminated
- Start
- Oct 2001
- Modality
- Reversible Covalent Inhibitors
- Countries
- 1
01
Overview
A Phase 4 trial of ceftazidime in cystic fibrosis (CF), Pseudomonas aeruginosa infection. Started Oct 2001; status: terminated.
02
Drugs
ceftazidime
03
Conditions
cystic fibrosis (CF)Pseudomonas aeruginosa infection
Beyond the preview
Go deeper on NCT00333385.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00333385.